NeuroPace
NASDAQ: NPCEMountain View, US · Delaware corporation · 2 known investors
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Digital HealthHardwareHealthtechMedical Devices
Founders & leadership
RK
Rebecca KuhnExecutive
FF
Frank FischerExecutive
VB
Vince BurgessNamed on SEC filing
RR
Renee RyanNamed on SEC filing
RL
Ray LarkinNamed on SEC filing
GG
Greg GarfieldNamed on SEC filing
MF
Mike FavetNamed on SEC filing
NK
Nael KassarNamed on SEC filing
Board
JS
JL
Joseph LacobBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$141.4M disclosed across 2 rounds · 2016–2020
▶$69.4MraisedAug 2020 · 23 investors · Other Health CareRule 506(b)
▶$69.4MraisedAug 2020 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nael KassarDirector
- Rebecca KuhnExecutive Officer
- Mike FavetExecutive Officer, Director
- Frank FischerExecutive Officer, Director
- Greg GarfieldDirector
- Renee RyanDirector
- Rishi GuptaDirector
- Vince BurgessDirector
- Evan NortonDirector
- Joseph LacobDirector
- Offering amount
- $96.4M
- Amount sold
- $69.4M
- Finders' fees
- $663.4K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$72MraisedAug 2017 · 26 investors · Other Health CareRule 506(b)
▶$72MraisedAug 2017 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rebecca KuhnExecutive Officer
- Vince BurgessDirector
- Renee RyanDirector
- Ray LarkinDirector
- Jonathan SilversteinDirector
- Frank FischerExecutive Officer, Director
- Joseph LacobDirector
- Greg GarfieldDirector
- Mike FavetDirector
- Nael KassarDirector
- Offering amount
- $80M
- Amount sold
- $72M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapPracto1058 shared keywordsPracto is a healthcare platform offering online video consultations with verified doctors across specialties and appointment booking for in-clinic visits. It serves patients in India, connecting them with doctors across areas such as dentistry, gynecology, pediatrics, and general medicine.
Vivian Health522 shared keywordsVivian is an online marketplace connecting healthcare professionals with staff, travel, local contract, and per diem jobs from employers and recruiters. It lets job seekers compare listings and communicate with recruiters in one place.
Companies competing with NeuroPace for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NeuroPace do?
- NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
- Who are NeuroPace's investors?
- NeuroPace's investors include Accelmed Partners, OrbiMed.
- How much funding has NeuroPace raised?
- NeuroPace has disclosed $141.4M raised across 2 rounds.
- Where is NeuroPace headquartered?
- NeuroPace is headquartered in Mountain View, US.